1Lee WY, Jin YT, Chang TW, et al. Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters. Histopathology, 1999,34(2):106～12.
2Takeno S, Noguchi T, Kikuchi R, et al. Prognostic value of cyclinB1 in patients with esophageal squamous cell carcinoma. Cancer, 2002,94(11): 2874～81.
3Soria JC, Jang SJ, Khuri FR, et al. Overexpression of cyclinB1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res, 2000,60(15): 4000～4.
4Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 1994, 266:66～71.
5Yang Q, Sakurai T, Mori I, et al. Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas. Cancer, 2001, 92(1): 54～60.
6MacLachlan TK, Somasundaram K, Sgagias M, et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem, 2000,275(4): 2777～85.
7沈镇宙主编. 现代乳腺肿瘤学进展. 上海:上海科学技术文献出版社,2002:19-36.
8Collecchi P, Santoni T, Gnesi E, et al. Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas. Cytometry, 2000,42(4):254～60.
9Megha T, Lazzi S, Ferrari F, et al. Expression of the G2-M checkpoint regulators cyclinB1 and P34CDC2 in breast cancer: a correlation with cellular kinetics. Anticancer Res, 1999,19(1A):163～9.
10Miyoshi Y, Iwao K, Takahashi Y, et al. Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancers. Cancer Lett, 2000,159(2):211～6.
